The Infectious Diseases Society of America and the HIV Medicine Association welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.

The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.

Dr. Marrazzo is an exceptional infectious diseases physician, leader, mentor and scientist who has dedicated her career to key areas of research, including sexually transmitted infections, HIV and antimicrobial resistance.

HIVMA is encouraged by the Senate FY 2024 Labor, Health and Human Services funding bill advanced by the Appropriations Committee, which sustains critical investments in the Ryan White HIV/AIDS Program, the Ending the HIV Epidemic in the U.S. initiative, and the Centers for Disease Control and Prevention’s efforts to establish the foundation for a national PrEP program.

House LHHS Appropriations Bill Harmful to the HIV Response HIVMA calls on the Senate to preserve funding for the Ending the HIV Epidemic initiative, Ryan White Program, NIH other essential programs, including PrEP access at the CDC.

Today’s ruling striking down the preventive services provision of the Affordable Care Act is a major setback to ending HIV as an epidemic and for improving the health of Americans by preventing the spread of other infectious diseases in the United States.

HIVMA Chair Michelle Cespedes, MD, MS welcomes the release of new draft guidance recommending deferrals based on individual risk assessment rather than a broad exclusion of an entire community.

The life expectancy  of non-Hispanic Black men who have sex with men  and who acquire HIV is 6.3 years shorter than their White counterparts when receiving status quo HIV care in the United States, according to simulation modeling findings presented at IDWeek.